Cargando…

Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements

Colon targeted drug delivery systems have gained a great deal of attention as potential carriers for the local treatment of colonic diseases with reduced systemic side effects and also for the enhanced oral delivery of various therapeutics vulnerable to acidic and enzymatic degradation in the upper...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sang Hoon, Bajracharya, Rajiv, Min, Jeong Youn, Han, Ji-Won, Park, Byeong Ju, Han, Hyo-Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022598/
https://www.ncbi.nlm.nih.gov/pubmed/31952340
http://dx.doi.org/10.3390/pharmaceutics12010068
_version_ 1783498052519067648
author Lee, Sang Hoon
Bajracharya, Rajiv
Min, Jeong Youn
Han, Ji-Won
Park, Byeong Ju
Han, Hyo-Kyung
author_facet Lee, Sang Hoon
Bajracharya, Rajiv
Min, Jeong Youn
Han, Ji-Won
Park, Byeong Ju
Han, Hyo-Kyung
author_sort Lee, Sang Hoon
collection PubMed
description Colon targeted drug delivery systems have gained a great deal of attention as potential carriers for the local treatment of colonic diseases with reduced systemic side effects and also for the enhanced oral delivery of various therapeutics vulnerable to acidic and enzymatic degradation in the upper gastrointestinal tract. In recent years, the global pharmaceutical market for biologics has grown, and increasing demand for a more patient-friendly drug administration system highlights the importance of colonic drug delivery as a noninvasive delivery approach for macromolecules. Colon-targeted drug delivery systems for macromolecules can provide therapeutic benefits including better patient compliance (because they are pain-free and can be self-administered) and lower costs. Therefore, to achieve more efficient colonic drug delivery for local or systemic drug effects, various strategies have been explored including pH-dependent systems, enzyme-triggered systems, receptor-mediated systems, and magnetically-driven systems. In this review, recent advancements in various approaches for designing colon targeted drug delivery systems and their pharmaceutical applications are covered with a particular emphasis on formulation technologies.
format Online
Article
Text
id pubmed-7022598
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70225982020-03-09 Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements Lee, Sang Hoon Bajracharya, Rajiv Min, Jeong Youn Han, Ji-Won Park, Byeong Ju Han, Hyo-Kyung Pharmaceutics Review Colon targeted drug delivery systems have gained a great deal of attention as potential carriers for the local treatment of colonic diseases with reduced systemic side effects and also for the enhanced oral delivery of various therapeutics vulnerable to acidic and enzymatic degradation in the upper gastrointestinal tract. In recent years, the global pharmaceutical market for biologics has grown, and increasing demand for a more patient-friendly drug administration system highlights the importance of colonic drug delivery as a noninvasive delivery approach for macromolecules. Colon-targeted drug delivery systems for macromolecules can provide therapeutic benefits including better patient compliance (because they are pain-free and can be self-administered) and lower costs. Therefore, to achieve more efficient colonic drug delivery for local or systemic drug effects, various strategies have been explored including pH-dependent systems, enzyme-triggered systems, receptor-mediated systems, and magnetically-driven systems. In this review, recent advancements in various approaches for designing colon targeted drug delivery systems and their pharmaceutical applications are covered with a particular emphasis on formulation technologies. MDPI 2020-01-15 /pmc/articles/PMC7022598/ /pubmed/31952340 http://dx.doi.org/10.3390/pharmaceutics12010068 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Lee, Sang Hoon
Bajracharya, Rajiv
Min, Jeong Youn
Han, Ji-Won
Park, Byeong Ju
Han, Hyo-Kyung
Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements
title Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements
title_full Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements
title_fullStr Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements
title_full_unstemmed Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements
title_short Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements
title_sort strategic approaches for colon targeted drug delivery: an overview of recent advancements
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7022598/
https://www.ncbi.nlm.nih.gov/pubmed/31952340
http://dx.doi.org/10.3390/pharmaceutics12010068
work_keys_str_mv AT leesanghoon strategicapproachesforcolontargeteddrugdeliveryanoverviewofrecentadvancements
AT bajracharyarajiv strategicapproachesforcolontargeteddrugdeliveryanoverviewofrecentadvancements
AT minjeongyoun strategicapproachesforcolontargeteddrugdeliveryanoverviewofrecentadvancements
AT hanjiwon strategicapproachesforcolontargeteddrugdeliveryanoverviewofrecentadvancements
AT parkbyeongju strategicapproachesforcolontargeteddrugdeliveryanoverviewofrecentadvancements
AT hanhyokyung strategicapproachesforcolontargeteddrugdeliveryanoverviewofrecentadvancements